Clinical Trials
2 trialsNCT06631092 2026-05-26
Personalised Neoantigen-targeting Cancer Vaccine NECVAX-NEO1 in Neoadjuvant Triple-negative Breast Cancer
NEC Bio B.V
Phase 1/2 Recruiting
NCT05799144 2025-10-22
pBI-11 & TA-HPV (With Pembrolizumab as Treatment for Patients w/Advanced, PD-L1 CPS≥1, hrHPV+ Oropharyngeal Cancer
Vanderbilt-Ingram Cancer Center
Phase 2 Recruiting